Erste Asset Management GmbH purchased a new position in MeiraGTx Holdings plc (NASDAQ:MGTX - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 669,702 shares of the company's stock, valued at approximately $2,795,000. Erste Asset Management GmbH owned approximately 1.03% of MeiraGTx as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BNP Paribas Financial Markets raised its stake in MeiraGTx by 142.5% during the third quarter. BNP Paribas Financial Markets now owns 9,319 shares of the company's stock worth $39,000 after acquiring an additional 5,476 shares during the period. China Universal Asset Management Co. Ltd. raised its position in shares of MeiraGTx by 97.0% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 14,886 shares of the company's stock worth $62,000 after purchasing an additional 7,330 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in shares of MeiraGTx by 19.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,763 shares of the company's stock worth $75,000 after purchasing an additional 2,839 shares during the last quarter. SG Americas Securities LLC acquired a new position in MeiraGTx during the 3rd quarter valued at approximately $82,000. Finally, Panagora Asset Management Inc. bought a new position in MeiraGTx during the 2nd quarter worth $97,000. 67.48% of the stock is owned by institutional investors.
MeiraGTx Stock Down 5.9 %
Shares of MeiraGTx stock traded down $0.39 during trading on Tuesday, hitting $6.25. 240,509 shares of the stock traded hands, compared to its average volume of 203,473. The company has a fifty day moving average price of $5.59 and a two-hundred day moving average price of $4.88. MeiraGTx Holdings plc has a twelve month low of $3.85 and a twelve month high of $7.60. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.86.
Analysts Set New Price Targets
A number of research firms have recently weighed in on MGTX. Chardan Capital reaffirmed a "buy" rating and set a $36.00 price target on shares of MeiraGTx in a report on Monday, November 18th. Royal Bank of Canada lifted their target price on MeiraGTx from $9.00 to $11.00 and gave the company an "outperform" rating in a research note on Thursday, November 14th.
View Our Latest Stock Report on MGTX
MeiraGTx Company Profile
(
Free Report)
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.
See Also
Before you consider MeiraGTx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MeiraGTx wasn't on the list.
While MeiraGTx currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
